Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

InterDigital Q1 Profit Declines

RELATED NEWS
Trade IDCC now with 

Wireless technologies company InterDigital Inc. (IDCC: Quote) posted a lower profit in the first-quarter due to lower revenue and higher intellectual property enforcement and non-patent litigation costs.

For the first-quarter, net income was $10.9 million or $0.24 per share, down 53 percent from $23.3 million or $0.51 per share last year.

Revenue for the quarter declined 12 percent to $69.31 million from $78.46 million in the prior year period.

On average, four analysts polled by Thomson Reuters expected earnings of $0.31 per share on revenues of $69.67 million.

Click here to receive FREE breaking news email alerts for InterDigital Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Yeast bloodstream infections, which are caused by Candida species, are a type of fungal infection, and if untreated, can result in serious medical complications. People who have a weak immune system, or are hospitalized in intensive care units, or have kidney disease needing dialysis, or have had abdominal surgery are said to be at risk of developing yeast bloodstream infections. After moving mostly higher over the course of the previous week, stocks showed a notable move back to the downside during trading on Monday. With the drop on the day, the Dow pulled back well off last Friday's record closing high. After reporting four consecutive monthly increases, the National Association of Realtors released a report on Monday showing an unexpected drop in U.S. existing home sales in the month of August. NAR said existing home sales fell 1.8 percent to a seasonally adjusted annual rate of 5.05 million in August.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.